7,773
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Elevated liver enzymes and adverse outcomes among patients with preeclampsia with severe features

, , &
Article: 2160627 | Received 09 Sep 2022, Accepted 14 Dec 2022, Published online: 04 Jan 2023

Figures & data

Figure 1. Flow diagram for study inclusion.

LFTs, liver function tests.

aExcluded patients with chronic hypertension with superimposed preeclampsia who did not meet criteria for preeclampsia with severe features.

bBased on OHSU lab values, where an AST ≥82 U/L and an ALT ≥120 U/L are considered two times the upper limit of normal or above threshold LFTs.

Figure 1. Flow diagram for study inclusion.LFTs, liver function tests.aExcluded patients with chronic hypertension with superimposed preeclampsia who did not meet criteria for preeclampsia with severe features.bBased on OHSU lab values, where an AST ≥82 U/L and an ALT ≥120 U/L are considered two times the upper limit of normal or above threshold LFTs.

Table 1. Adverse maternal and neonatal outcomes among patients with preeclampsia with severe featuresa stratified by elevated liver enzymes pre-delivery.

Supplemental material

Supplemental Material

Download MS Word (35 KB)